TEL AVIV, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...
TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...
Nasus Pharma has presented data from a pivotal trial of its opioid overdose treatment. The naloxone powder-based nasal spray was absorbed into the blood faster than Narcan, leading Nasus to detail ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback